CC vs VHI
CC: Chemours is a global performance chemicals provider specializing in titanium technologies, fluoroproducts, and advanced materials for critical industrial and consumer applications. VHI: A diversified holding company with major interests in global titanium dioxide production, specialty security hardware, and Nevada real estate development.
Side-by-side fundamentals
| Metric | CC | VHI | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $13.83 | $14.91 | |
| Market cap | $2.1B | $422M | |
| Net margin FY2025, SEC XBRL | -6.6% | -2.8% | VHI higher |
| Gross margin FY2025, SEC XBRL | +15.5% | +14.2% | CC higher |
| Operating margin FY2025, SEC XBRL | n/a | +3.0% | |
| ROE FY2025, SEC XBRL | -68.1% | -4.2% | VHI higher |
| ROA FY2025, SEC XBRL | -5.2% | -2.2% | VHI higher |
| Debt / equity as of 2026-09-03 | 19.24 | 0.61 | VHI lower |
| Revenue growth (YoY) as of 2026-09-03 | -1.4% | -0.7% | VHI higher |
| Revenue CAGR (3y) SEC XBRL | -5.3% | -2.2% | VHI higher |
| Dividend yield as of 2026-09-03 | +2.5% | +1.9% | CC higher |
| Dividend streak (yrs) SEC XBRL | 1 | 5 | VHI higher |
| Beta as of 2026-09-03 | 1.81 | 0.91 | |
| 1-year return as of 2026-10-08 close | -8.0% | -2.9% | VHI higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.